Company Name: Foundation Medicine, Inc.
Foundation Medicine, Inc. provides a molecular information platform that is designed to analyze specimens for cancer. The company’s products are used by physicians as well as drug developers. The company’s clinical assays include:
- FoundationOne (solid tumors)
- Foundationone Heme (hematologic malignancies)
Ticker Symbol: FMI (NASDAQ)
Company Website: www.foundationmedicine.com
Social Media: Foundation Medicine LinkedIn
Headquarters: Cambridge, MA